The US FDA Approves MED-EL’s Sonnet 3 Audio Processor for Optimal Hearing
Shots:
- The US FDA has approved the Sonnet 3 audio processor for MED-EL cochlear implants; commercially available in early 2025. Also, Pts implanted with MED-EL as of Sep 1, 2024, can access one-time exchange for Sonnet 3 in the TechSwap Program
- Sonnet 3 is 2g lighter & ~18% shorter than Sonnet 2 with features like ASM 3.0 tech, which auto-adjusts settings to reduce background noise & uses dual mics to improve focus on conversations
- Sonnet 3 supports binaural streaming where users can pair it with other AudioStream processors & compatible devices for optimal hearing, while also offering touch key for program changes, a flexible earhook for comfort, & an IP68 waterproof design
Ref: Businesswire | Image: MED-EL
Related News:- Navi Medical Technologies Receives the US FDA’s 510(k) Clearance for Neonav ECG Tip Location System
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
